In this issue of Cell Host & Microbe, Leonardi et al. demonstrate ulcerative colitis patients with high Candida responded best to fecal microbial transplant (FMT). However, decreased Candida post-treatment was associated with improved disease—suggesting that Candida reductions are associated with less inflammation. Pre-FMT Candida levels may identify FMT responders.